Skip to content
2000
Volume 21, Issue 12
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Retinal vein occlusion (RVO) is one of the most prevalent causes of visual loss in the Western World. Its pathogenesis is still not completely known. Chronic macular edema and ischemia compromise the functional and anatomical status of the retina. Antivascular endothelial growth factor (anti-VEGF) injections have demonstrated better results than other previous options, including observation or laser therapy. This narrative review aims to analyze the current aspects related to these drugs.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/1389450121666200428101343
2020-09-01
2025-05-08
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/1389450121666200428101343
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test